Don’t Stop Post–Sustained Virologic Response Hepatocellular Carcinoma Surveillance Just Yet!
暂无分享,去创建一个
[1] M. Buti,et al. Non-invasive prediction of liver related events in HCV compensated advanced chronic liver disease patients after oral antivirals. , 2020, Journal of hepatology.
[2] María Teresa Salcedo Allende,et al. Transient elastography in direct acting antiviral era. Relation between liver stiffness measurement after sustained virological response and histology. , 2019, Journal of viral hepatitis.
[3] J. Macías,et al. Liver stiffness at the time of sustained virological response predicts the clinical outcome in HIV/HCV-coinfected patients with advanced fibrosis treated with direct-acting antivirals. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] R. Sterling,et al. Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores. , 2019, Gastroenterology.
[5] M. Imamura,et al. HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response , 2019, Gastroenterology.
[6] V. de Lédinghen,et al. Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study , 2019, PloS one.
[7] Jill Waalen,et al. Morphometry Confirms Fibrosis Regression From Sustained Virologic Response to Direct‐Acting Antivirals for Hepatitis C , 2018, Hepatology communications.
[8] Siddharth Singh,et al. American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis. , 2017, Gastroenterology.
[9] V. de Lédinghen,et al. Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®). , 2014, Journal of hepatology.
[10] R. Bañares,et al. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] V. Paradis,et al. The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response. , 2013, Journal of hepatology.
[12] E. Cholongitas,et al. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. , 2011, Journal of hepatology.
[13] V. de Lédinghen,et al. Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients. , 2008, Journal of hepatology.
[14] J. Pawlotsky,et al. EASL Recommendations on Treatment of Hepatitis C 2015. , 2015, Journal of hepatology.